Health IT

Acurx Pharma's new drug, ibezapolstat, offers a novel weapon against deadly infections like C. diff by sparing good bacteria. Is this the breakthrough we need?

A new AI platform promises to slash drug development red tape. But can it overcome the industry’s deep-rooted challenges of privacy, trust, and integration?

As USANA marks 10 years of its World Service Week, a closer look reveals how its direct-selling network is strategically engineered to power a global charity.

Renowned cancer researcher Dr. Morag Park takes the helm at the Gairdner Foundation, a key predictor of Nobel Prizes. What does this strategic move mean for global science?

Faculty's new AI developer studio promises to cut drug trial planning from weeks to minutes, a major growth signal in the high-stakes life sciences race.

Emory Healthcare's migration to Sectra One Cloud is more than a tech upgrade. It's a strategic blueprint for the future of medicine.

Preliminary data from a randomized trial suggests a personalized medicine approach can reverse cognitive decline, offering a glimmer of hope beyond slowing the disease.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?

MedPro Healthcare Staffing's seventh consecutive Top Workplace award isn't just a trophy; it's a strategic asset in the war for talent. But what does it mean?

Adaptive Biotechnologies' new debt offering is more than a financial tune-up; it's a calculated move to sever a costly royalty deal and arm its star MRD division for a separate future.

A new AI tool is shifting post-acute care from relationship-based referrals to data-driven strategy by analyzing entire physician groups, not just doctors.

The FDA's approval of a new Type 1 Diabetes therapy is a landmark. But the real story is the collaborative engine clearing the path for future breakthroughs.

A strategic integration between Onera Health and ResMed's Somnoware is set to dismantle the biggest barriers in sleep medicine by moving gold-standard tests home.

A Texas-based, private equity-backed firm just acquired a beloved local dermatology practice. It’s a story of national expansion, but what does it mean for care?

BetterAge's new executive team signals a potent strategy: combining deep industry partnerships with advanced AI to scale in the competitive elder care market.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

Tri Delta’s 27-year, $185M partnership with St. Jude is more than charity. It's a masterclass in grassroots economic power fueling life-saving innovation.

As biopharma navigates a maze of privacy laws and AI, a new platform aims to centralize patient consent, turning a compliance nightmare into a bridge for trust.

A record $10M gift establishes a new research chair, honoring a titan of Canadian finance and positioning Montreal to solve the critical organ shortage.

As AI promises to revolutionize medicine, enterprises face complex challenges. A new ISG study aims to chart the critical partner ecosystem.